Skip to main content
Article thumbnail
Location of Repository

Indonesia, H5N1, and global health diplomacy

By Rachel Irwin


The World Health Organization (WHO) is mandated to be the United Nations specialized agency for health. However, in light of changing disease trends, the increased “globalization” of health, and the entry of other actors into the health arena, much of the current discourse in global health research discusses the future of the WHO and its current role in governing global health, and how this should, or can change. This paper examines the role of the WHO in global health diplomacy and the promotion of global health security by examining the Indonesian virus-sharing case. In 2007, the Indonesian government pulled out of the Global Influenza Surveillance Network (GISN), concerned that its strains of H5N1 would be used to make vaccines in the high-income countries which would then be “resold” to Indonesia at what they considered to be unaffordable prices. They were also concerned that scientists in high-income countries would be able to take out patents based on these strains, which they asserted was their sovereign property. This paper discusses to what extent the International Health Regulations (IHR) and other agreements are applicable to this case and why countries have chosen to address this issue through an intergovernmental process rather than invoking the IHR. It also questions the enforceability of international agreements and their role in promoting equity. This paper then examines why current negotiations over virus-sharing have not reached an agreement. In doing so we can use this case to ask broader question about what “effective” global health diplomacy is, how global health governance architecture could, and should change – and what should the WHO’s role in promoting global health security be, and what other actors could, and should be involved

Topics: JZ International relations, RA Public aspects of medicine
Publisher: Center for Global Health Studies, Seton Hall University
Year: 2010
OAI identifier:
Provided by: LSE Research Online

Suggested articles


  1. (2007). 18 “Indonesia to resume sharing H5N1 avian influenza virus samples following a WHO meeting in
  2. (2010). 30 World Health Organization, “Follow-up Action on Pending Issues.” 31 “WHO Backs Indonesia's Initiative To Form Influenza Research Centre,” ANTARA News,
  3. (2005). 35 World Health Organization, International Health Regulations, doi
  4. (2010). 565. 39 Lee, The World Health Organization.
  5. (2005). 59 World Health Organization Executive Board, “Implementation of the International Health Regulations
  6. (2008). 9 Endang Sedyaningsih. Siti Isfandari, Triono Soendoro and Siti Fadilah Supari, “Towards Mutual Trust, Transparency and Equity in Virus Sharing Mechanism: The Avian Influenza Case of
  7. (2006). A global initiative on sharing avian flu data,” doi
  8. (2005). Another benefit is empowerment though strengthening capacity. The
  9. (2008). Creating a committee C of the World Health Assembly,” Lancet Infectious Diseases 371, doi
  10. (2009). Disease outbreaks and health governance in the Asia-Pacific: Australia's role in the region,” doi
  11. (2007). Dispute resolved over sharing avian influenza virus samples,” doi
  12. (2007). Gaudenz Silberschmidt and Paulo Buss, “Global Health Diplomacy: the need for new perspectives, strategic approaches and skills in global health,” doi
  13. (2009). Global Health Security: A Team to Engage the Foreign Office (London: Royal Institute of International Affairs,
  14. Indonesia earns Flu Accord,” 1108. 17 Morris, “Dispute resolved over sharing,” doi
  15. Indonesia earns Flu Accord,” 1108. 21 Ibid. 22 Morris, “Dispute resolved over sharing,” 310. 23 Garrett and Fidler,
  16. Indonesia earns Flu Accord,” 1108. 64 Yamada, Dautry and Walporty, “Ready for the Avian Flu?” 162. 65 Lee, The World Health Organization (WHO). doi
  17. (2008). Influenza Virus Samples, doi
  18. (2008). Nicolas Collin, Xavier de Radigues and the World Health Organization H1N1 Vaccine Task Force, “Vaccine production capacity for seasonal and pandemic (H1N1) doi
  19. (2009). Overcoming Constraints of State Sovereignty: global health governance in doi
  20. (2009). SARS: Wake-Up Call,” 69 Devi Sridhar, “Questions for the G20: A crisis response or real governance change?”
  21. (2008). Schnirring, “HHS secretary blogs on impasse with Indonesia,” CIDRAP,
  22. (2007). Sharing H5N1 Viruses to Stop a Global Influenza Pandemic,” doi
  23. (2010). Taking this debate outside the context of the UN system, the G8, G20 and regional groups may fill some of the gaps within global health governance. Health
  24. (2009). The World Health Organization (WHO), doi
  25. (2009). Use of Revised International Health Regulations during Influenza A (H1N1) Epidemic, doi
  26. (2003). Wake-Up Call for a Strong Global Health Policy,” YaleGlobal Online Magazine,
  27. (2008). WHO’s budgetary allocations and burden of disease: a comparative analysis,” Lancet Infectious Diseases 372, doi
  28. (2010). with regular budget of $1 billion66 the WHO is limited in what it can do, even within health.67 Although this initially seems a large amount, one must

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.